Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 26% ± 9% | |
regulatory T cell | 5 studies | 16% ± 1% | |
natural killer cell | 4 studies | 16% ± 1% | |
CD4-positive, alpha-beta T cell | 4 studies | 17% ± 1% | |
epithelial cell | 4 studies | 34% ± 9% | |
fibroblast | 4 studies | 24% ± 7% | |
basal cell | 4 studies | 32% ± 22% | |
astrocyte | 4 studies | 21% ± 6% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 18% ± 1% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
ciliated cell | 3 studies | 24% ± 9% | |
lymphocyte | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 35% ± 10% | |
glutamatergic neuron | 3 studies | 40% ± 14% | |
effector memory CD4-positive, alpha-beta T cell | 3 studies | 19% ± 5% | |
oligodendrocyte | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 1449.88 | 358 / 359 | 100% | 13.39 | 286 / 286 |
intestine | 100% | 1987.64 | 966 / 966 | 99% | 13.31 | 524 / 527 |
esophagus | 100% | 1815.71 | 1443 / 1445 | 99% | 10.97 | 181 / 183 |
lung | 100% | 1965.59 | 578 / 578 | 98% | 12.09 | 1130 / 1155 |
breast | 100% | 2553.58 | 459 / 459 | 98% | 19.95 | 1091 / 1118 |
thymus | 100% | 2795.78 | 653 / 653 | 98% | 29.24 | 590 / 605 |
skin | 100% | 3662.20 | 1809 / 1809 | 97% | 21.89 | 459 / 472 |
pancreas | 99% | 1268.33 | 325 / 328 | 98% | 13.45 | 174 / 178 |
bladder | 100% | 2303.86 | 21 / 21 | 97% | 13.30 | 487 / 504 |
kidney | 100% | 1692.52 | 89 / 89 | 96% | 18.69 | 866 / 901 |
brain | 97% | 1019.80 | 2563 / 2642 | 99% | 19.56 | 697 / 705 |
prostate | 100% | 2174.67 | 245 / 245 | 96% | 16.41 | 480 / 502 |
ovary | 100% | 2982.82 | 180 / 180 | 93% | 9.75 | 402 / 430 |
uterus | 100% | 2818.99 | 170 / 170 | 91% | 11.95 | 418 / 459 |
liver | 99% | 944.43 | 224 / 226 | 87% | 10.23 | 352 / 406 |
adrenal gland | 99% | 1688.21 | 255 / 258 | 85% | 12.34 | 195 / 230 |
adipose | 100% | 2128.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2492.04 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2104.92 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.19 | 1 / 1 |
muscle | 99% | 1375.88 | 796 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.27 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 16.64 | 27 / 29 |
heart | 91% | 795.92 | 785 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 11.46 | 72 / 80 |
peripheral blood | 88% | 1530.29 | 813 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010996 | Biological process | response to auditory stimulus |
GO_0006281 | Biological process | DNA repair |
GO_0006289 | Biological process | nucleotide-excision repair |
GO_0070914 | Biological process | UV-damage excision repair |
GO_0000720 | Biological process | pyrimidine dimer repair by nucleotide-excision repair |
GO_0010224 | Biological process | response to UV-B |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0031573 | Biological process | mitotic intra-S DNA damage checkpoint signaling |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_1901990 | Biological process | regulation of mitotic cell cycle phase transition |
GO_0006298 | Biological process | mismatch repair |
GO_0005730 | Cellular component | nucleolus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005829 | Cellular component | cytosol |
GO_0000109 | Cellular component | nucleotide-excision repair complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0071942 | Cellular component | XPC complex |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000111 | Cellular component | nucleotide-excision repair factor 2 complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000404 | Molecular function | heteroduplex DNA loop binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0000405 | Molecular function | bubble DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0140612 | Molecular function | DNA damage sensor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | XPC |
Protein name | XPC complex subunit, DNA damage recognition and repair factor Mutant xeroderma pigmentosum group C DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125) Xeroderma pigmentosum, complementation group C isoform A Xeroderma pigmentosum complementation group C |
Synonyms | XPCC |
Description | FUNCTION: Involved in global genome nucleotide excision repair (GG-NER) by acting as damage sensing and DNA-binding factor component of the XPC complex . Has only a low DNA repair activity by itself which is stimulated by RAD23B and RAD23A. Has a preference to bind DNA containing a short single-stranded segment but not to damaged oligonucleotides . This feature is proposed to be related to a dynamic sensor function: XPC can rapidly screen duplex DNA for non-hydrogen-bonded bases by forming a transient nucleoprotein intermediate complex which matures into a stable recognition complex through an intrinsic single-stranded DNA-binding activity . The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex . The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs . The orientation of XPC complex binding appears to be crucial for inducing a productive NER . XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery . Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair . In vitro, the XPC:RAD23B dimer is sufficient to initiate NER; it preferentially binds to cisplatin and UV-damaged double-stranded DNA and also binds to a variety of chemically and structurally diverse DNA adducts . XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a preference for the 5' side. XPC:RAD23B induces a bend in DNA upon binding. XPC:RAD23B stimulates the activity of DNA glycosylases TDG and SMUG1 . .; FUNCTION: In absence of DNA repair, the XPC complex also acts as a transcription coactivator: XPC interacts with the DNA-binding transcription factor E2F1 at a subset of promoters to recruit KAT2A and histone acetyltransferase complexes (HAT) . KAT2A recruitment specifically promotes acetylation of histone variant H2A.Z.1/H2A.Z, but not H2A.Z.2/H2A.V, thereby promoting expression of target genes . . |
Accessions | D2CPJ5 D2CPJ2 E7EUB5 ENST00000476581.6 [Q01831-3] Q01831 D2CPK4 X5DRB1 D9I4E1 D2CPJ3 D2CPK0 D2CPJ4 ENST00000285021.12 [Q01831-1] D2CPK6 ENST00000511155.1 D2CPK7 D2CPK5 |